BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 35717621)

  • 21. Radiation-induced Oral Mucositis in Brazilian Patients: Prevalence and Associated Factors.
    Pereira IF; Firmino RT; Meira HC; DO Egito Vasconcelos BC; DE Souza Noronha VRA; Santos VR
    In Vivo; 2019; 33(2):605-609. PubMed ID: 30804148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pain management in patients undergoing radiation therapy for head and neck cancer - a descriptive study.
    Schaller AKCS; Peterson A; Bäckryd E
    Scand J Pain; 2021 Apr; 21(2):256-265. PubMed ID: 34387952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Laser Therapy as a Preventive Approach for Oral Mucositis in Cancer Patients Undergoing Chemotherapy: The Potential Role of Superoxide Dismutase.
    Menezes BC; Thebit MM; Bonela LAS; Oliveira KG; Gonçalves WL; Bissoli NS; Sartorio CL; Gouvea SA
    Asian Pac J Cancer Prev; 2021 Oct; 22(10):3211-3217. PubMed ID: 34710997
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomised controlled trial of Caphosol mouthwash in management of radiation-induced mucositis in head and neck cancer.
    Wong KH; Kuciejewska A; Sharabiani MTA; Ng-Cheng-Hin B; Hoy S; Hurley T; Rydon J; Grove L; Santos A; Ryugenji M; Bhide SA; Nutting CM; Harrington KJ; Newbold KL
    Radiother Oncol; 2017 Feb; 122(2):207-211. PubMed ID: 27393218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salivary Cytokine Levels and Oral Mucositis in Head and Neck Cancer Patients Treated With Chemotherapy and Radiation Therapy.
    Bossi P; Bergamini C; Miceli R; Cova A; Orlandi E; Resteghini C; Locati L; Alfieri S; Imbimbo M; Granata R; Mariani L; Iacovelli NA; Huber V; Cavallo A; Licitra L; Rivoltini L
    Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):959-966. PubMed ID: 27745982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of clinically relevant oral mucositis in outpatients receiving myelosuppressive chemotherapy for solid tumors.
    Wuketich S; Hienz SA; Marosi C
    Support Care Cancer; 2012 Jan; 20(1):175-83. PubMed ID: 21331484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma.
    Liu YJ; Zhu GP; Guan XY
    Oral Oncol; 2012 Jun; 48(6):554-9. PubMed ID: 22289637
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Randomized double-blind placebo-controlled trial of celecoxib for oral mucositis in patients receiving radiation therapy for head and neck cancer.
    Lalla RV; Choquette LE; Curley KF; Dowsett RJ; Feinn RS; Hegde UP; Pilbeam CC; Salner AL; Sonis ST; Peterson DE
    Oral Oncol; 2014 Nov; 50(11):1098-103. PubMed ID: 25151488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
    Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
    J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salivary alpha-1-antitrypsin and macrophage migration inhibitory factor may be potential prognostic biomarkers for oncologic treatment-induced severe oral mucositis.
    Palmier NR; Leme AFP; De Rossi T; Telles GP; Morais-Faria K; Kowalski LP; Marta GN; Brandão TB; Arany PR; Migliorati CA; Santos-Silva AR; Prado-Ribeiro AC
    Support Care Cancer; 2021 Jun; 29(6):2939-2946. PubMed ID: 33009579
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
    De Sanctis V; Bossi P; Sanguineti G; Trippa F; Ferrari D; Bacigalupo A; Ripamonti CI; Buglione M; Pergolizzi S; Langendjik JA; Murphy B; Raber-Durlacher J; Russi EG; Lalla RV
    Crit Rev Oncol Hematol; 2016 Apr; 100():147-66. PubMed ID: 26947812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of an elemental diet on oral mucositis of esophageal cancer patients treated with DCF chemotherapy: a multi-center prospective feasibility study (EPOC study).
    Tanaka Y; Ueno T; Yoshida N; Akutsu Y; Takeuchi H; Baba H; Matsubara H; Kitagawa Y; Yoshida K
    Esophagus; 2018 Oct; 15(4):239-248. PubMed ID: 30225745
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
    Bentzen SM; Saunders MI; Dische S; Bond SJ
    Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A retrospective study of oral adverse events with colorectal cancer chemotherapy using bevacizumab].
    Takahashi H; Sato M; Tsukada K; Tsuchiya S; Tanda S
    Gan To Kagaku Ryoho; 2011 Jun; 38(6):959-62. PubMed ID: 21677486
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe oral mucositis associated with cancer therapy: impact on oral functional status and quality of life.
    Cheng KK; Leung SF; Liang RH; Tai JW; Yeung RM; Thompson DR
    Support Care Cancer; 2010 Nov; 18(11):1477-85. PubMed ID: 19916030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of a Plantago ovata-based herbal compound in prevention and treatment of oral mucositis in patients with breast cancer receiving chemotherapy: A double-blind, randomized, controlled crossover trial.
    Hasheminasab FS; Hashemi SM; Dehghan A; Sharififar F; Setayesh M; Sasanpour P; Tasbandi M; Raeiszadeh M
    J Integr Med; 2020 May; 18(3):214-221. PubMed ID: 32268991
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of individual in vivo repair of DNA double-strand breaks on oral mucositis in adjuvant radiotherapy of head-and-neck cancer.
    Fleckenstein J; Kühne M; Seegmüller K; Derschang S; Melchior P; Gräber S; Fricke A; Rübe CE; Rübe C
    Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1465-72. PubMed ID: 20947264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attempts to Understand Oral Mucositis in Head and Neck Cancer Patients through Omics Studies: A Narrative Review.
    San Valentin EMD; Do KA; Yeung SJ; Reyes-Gibby CC
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069314
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma.
    Vera-Llonch M; Oster G; Hagiwara M; Sonis S
    Cancer; 2006 Jan; 106(2):329-36. PubMed ID: 16342066
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Review of oral mucositis treatment guidelines with an emphasis on laser therapy.
    Walinski CJ; Mellusi SM; Brodeur AE; Marchick E; Katz D; Van Putten M
    Gen Dent; 2022; 70(2):22-26. PubMed ID: 35225799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.